M. Caroline Vos

1.7k total citations
57 papers, 1.1k citations indexed

About

M. Caroline Vos is a scholar working on Oncology, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, M. Caroline Vos has authored 57 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 18 papers in Reproductive Medicine and 17 papers in Obstetrics and Gynecology. Recurrent topics in M. Caroline Vos's work include Cancer survivorship and care (19 papers), Ovarian cancer diagnosis and treatment (15 papers) and Endometrial and Cervical Cancer Treatments (14 papers). M. Caroline Vos is often cited by papers focused on Cancer survivorship and care (19 papers), Ovarian cancer diagnosis and treatment (15 papers) and Endometrial and Cervical Cancer Treatments (14 papers). M. Caroline Vos collaborates with scholars based in Netherlands, United States and United Kingdom. M. Caroline Vos's co-authors include Lonneke V. van de Poll‐Franse, Johanna M.A. Pijnenborg, Nicole P. M. Ezendam, Roy F.P.M. Kruitwagen, Dorry Boll, Brenda Pijlman, Leon F.A.G. Massuger, Belle H. de Rooij, Kim A.H. Nicolaije and Floortje Mols and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Cancer.

In The Last Decade

M. Caroline Vos

52 papers receiving 1.0k citations

Peers

Countries citing papers authored by M. Caroline Vos

Since Specialization

Citations

This map shows the geographic impact of M. Caroline Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Caroline Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Caroline Vos more than expected).

Fields of papers citing papers by M. Caroline Vos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Caroline Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Caroline Vos. The network helps show where M. Caroline Vos may publish in the future.

Co-authorship network of co-authors of M. Caroline Vos

This figure shows the co-authorship network connecting the top 25 collaborators of M. Caroline Vos. A scholar is included among the top collaborators of M. Caroline Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Caroline Vos. M. Caroline Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Factors contributing to long‐term vaginal pessary use: A mixed‐methods study 2025 ·International Journal of Gynecology & Obstetrics ·(unknown), (unknown), (unknown), Arie Franx, M. Caroline Vos	0
2	The influence of decisional conflict on treatment decision in pelvic organ prolapse—data from the SHADE-POP trial 2024 ·Archives of Gynecology and Obstetrics ·(unknown), (unknown), (unknown), Arie Franx, M. Caroline Vos	0
3	Functional estrogen receptor signal transduction pathway activity and antihormonal therapy response in low‐grade ovarian carcinoma 2023 ·Cancer ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Christianne Lok, Joanne A. de Hullu, H.P.M. Smedts, M. Caroline Vos, Brenda Pijlman, Loes Kooreman, Johan Bulten, (unknown), Steven L. Bosch, Anja van de Stolpe, Sandrina Lambrechts, Ruud L.M. Bekkers, Jurgen M.J. Piek	4
4	Patient characteristics and factors contributing to recurrence of bacterial vaginosis presented in primary care 2023 ·Family Practice ·(unknown), Annemarie Uijen, M. Caroline Vos, Reinier Akkermans, A.L.M. Lagro‐Janssen, Doreth Teunissen	1
5	Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer 2022 ·International Journal of Gynecological Cancer ·(unknown), Johanna M.A. Pijnenborg, Louis J.M. van der Putten, Johan Bulten, Marc P.L.M. Snijders, Heidi V.N. Küsters‐Vandevelde, (unknown), M. Caroline Vos, (unknown), Astrid Eijkelenboom, Joanne A. de Hullu, Casper Reijnen	3
6	SHAred DEcision making in Pelvic Organ Prolapse (SHADE-POP); Implementation is not as easy as it seems 2021 ·Patient Education and Counseling ·(unknown), (unknown), (unknown), (unknown), Nicole P. M. Ezendam, (unknown), (unknown), M. Caroline Vos	2
7	The role of MMP-14 in ovarian cancer: a systematic review 2021 ·Journal of Ovarian Research ·M. Caroline Vos, A.A.M. van der Wurff, Toin H. Van Kuppevelt, Leon F.A.G. Massuger	26
8	Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy 2021 ·Gynecologic Oncology ·Miranda P. Steenbeek, (unknown), Marline G. Harmsen, Nicoline Hoogerbrugge, Helena C. van Doorn, (unknown), Marc van Beurden, Ronald P. Zweemer, Katja N. Gaarenstroom, (unknown), (unknown), M. Caroline Vos, Jurgen M.J. Piek, Luc R.C.W. van Lonkhuijzen, Mirjam J. A. Apperloo, S.F.P.J. Coppus, Joanna IntHout, Joanne A. de Hullu, Rosella Hermens	2
9	Primary Ovarian Tumors With Lymphogenic and Hematogenic Metastasis Express High MMP-14, Which Colocalizes With Highly Sulfated Chondroitin Sulfate in the Stroma 2019 ·International Journal of Gynecological Pathology ·M. Caroline Vos, Eva Hollemans, (unknown), Toin H. Van Kuppevelt, A.A.M. van der Wurff, Leon F.A.G. Massuger	3
10	Presence of gastro-intestinal symptoms in ovarian cancer patients during survivorship: a cross-sectional study from the PROFILES registry 2018 ·Supportive Care in Cancer ·(unknown), Olga Husson, M. Caroline Vos, Lonneke V. van de Poll‐Franse, Petronella B. Ottevanger, Nicole P. M. Ezendam	7
11	A patient decision aid for risk‐reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing 2017 ·Health Expectations ·Marline G. Harmsen, Miranda P. Steenbeek, Nicoline Hoogerbrugge, Helena C. van Doorn, Katja N. Gaarenstroom, M. Caroline Vos, Leon F.A.G. Massuger, Joanne A. de Hullu, Rosella Hermens	14
12	Illness perceptions and changes in lifestyle following a gynecological cancer diagnosis: A longitudinal analysis 2017 ·Gynecologic Oncology ·(unknown), Belle H. de Rooij, Johanna M.A. Pijnenborg, M. Caroline Vos, Dorry Boll, Roy F.P.M. Kruitwagen, Lonneke V. van de Poll‐Franse, Nicole P. M. Ezendam	20
13	Limited independent prognostic value of MMP-14 and MMP-2 expression in ovarian cancer 2016 ·Diagnostic Pathology ·M. Caroline Vos, A.A.M. van der Wurff, Johan Bulten, (unknown), (unknown), Toin H. Van Kuppevelt, Thijs Hendriks, Leon F.A.G. Massuger	17
14	Factors influencing implementation of a survivorship care plan—a quantitative process evaluation of the ROGY Care trial 2016 ·Journal of Cancer Survivorship ·Belle H. de Rooij, Nicole P. M. Ezendam, Kim A.H. Nicolaije, M. Caroline Vos, Johanna M.A. Pijnenborg, Dorry Boll, Roy F.P.M. Kruitwagen, Lonneke V. van de Poll‐Franse	10
15	Paper-Based Survivorship Care Plans May be Less Helpful for Cancer Patients Who Search for Disease-Related Information on the Internet: Results of the Registrationsystem Oncological Gynecology (ROGY) Care Randomized Trial 2016 ·Journal of Medical Internet Research ·Kim A.H. Nicolaije, Nicole P. M. Ezendam, Johanna M.A. Pijnenborg, Dorry Boll, M. Caroline Vos, Roy F.P.M. Kruitwagen, Lonneke V. van de Poll‐Franse	8
16	PIpelle Prospective ENDOmetrial carcinoma (PIPENDO) study, pre-operative recognition of high risk endometrial carcinoma: a multicentre prospective cohort study 2015 ·BMC Cancer ·Nicole C.M. Visser, Johan Bulten, A.A.M. van der Wurff, Erik A. Boss, Carolien M. Bronkhorst, (unknown), (unknown), (unknown), (unknown), Paul J. J. M. Klinkhamer, Brenda Pijlman, Marc P.M.L. Snijders, Ingrid Vandenput, M. Caroline Vos, P.E.J. de Wit, Lonneke V. van de Poll‐Franse, Leon F.A.G. Massuger, Johanna M.A. Pijnenborg	14
17	Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: Results from the population-based PROFILES registry 2014 ·Gynecologic Oncology ·Nicole P. M. Ezendam, Brenda Pijlman, (unknown), Hans Pruijt, Floortje Mols, M. Caroline Vos, Johanna M.A. Pijnenborg, Lonneke V. van de Poll‐Franse	113
18	The impact of a cancer Survivorship Care Plan on gynecological cancer patient and health care provider reported outcomes (ROGY Care): study protocol for a pragmatic cluster randomized controlled trial 2011 ·Trials ·Lonneke V. van de Poll‐Franse, Kim A.H. Nicolaije, M. Caroline Vos, Johanna M.A. Pijnenborg, Dorry Boll, Olga Husson, (unknown), Erik A. Boss, Ralph H.M. Hermans, (unknown), (unknown), Brenda Pijlman, (unknown), H Mertens, (unknown), Johannes J. van Beek, Jan A. Roukema, Roy F.P.M. Kruitwagen	35
19	Clinical Value of Morphometric and DNA Flow Cytometric Variables as Independent Predictors of Survival in Epithelial Ovarian Carcinoma: A 5-year Follow-up Study 2009 ·International Journal of Gynecological Pathology ·(unknown), A.A.M. van der Wurff, (unknown), Roy F.P.M. Kruitwagen, (unknown), M. Caroline Vos	2
20	TVT-O versus Monarc after a 2–4-year follow-up: a prospective comparative study 2009 ·International Urogynecology Journal ·Roderick M. Houwert, (unknown), M. Caroline Vos, Harry A.M. Vervest	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact